BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN)
CUSIP: 09061G101
Q1 2018 13F Holders as of 31 Mar 2018
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 192,975,286
- Total 13F shares
- 180,119,807
- Share change
- +2,417,591
- Total reported value
- $14,603,106,292
- Put/Call ratio
- 130%
- Price per share
- $81.07
- Number of holders
- 421
- Value change
- +$188,116,053
- Number of buys
- 187
- Number of sells
- 203
Quarterly Holders Quick Answers
What is CUSIP 09061G101?
CUSIP 09061G101 identifies BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09061G101:
Top shareholders of BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Capital Research Global Investors |
13F
|
Company |
11%
|
21,500,859
|
$1,917,232,000 | — | 31 Dec 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.6%
|
14,735,730
|
$1,313,986,000 | — | 31 Dec 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
6.6%
|
12,819,744
|
$1,143,135,000 | — | 31 Dec 2017 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
6.1%
|
11,809,695
|
$1,053,071,000 | — | 31 Dec 2017 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
5.3%
|
10,245,295
|
$913,573,000 | — | 31 Dec 2017 | |
| SANDS CAPITAL MANAGEMENT, LLC |
13F
|
Company |
4%
|
7,726,778
|
$688,997,000 | — | 31 Dec 2017 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
3.9%
|
7,583,084
|
$676,184,000 | — | 31 Dec 2017 | |
| FMR LLC |
13F
|
Company |
3.1%
|
5,970,333
|
$532,375,000 | — | 31 Dec 2017 | |
| Invesco Ltd. |
13F
|
Company |
2.3%
|
4,513,641
|
$402,480,000 | — | 31 Dec 2017 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
3,994,575
|
$356,207,000 | — | 31 Dec 2017 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
1.8%
|
3,472,712
|
$309,662,000 | — | 31 Dec 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.5%
|
2,865,502
|
$255,517,000 | — | 31 Dec 2017 | |
| Palo Alto Investors LP |
13F
|
Company |
1.3%
|
2,497,806
|
$222,729,000 | — | 31 Dec 2017 | |
| WADDELL & REED FINANCIAL INC |
13F
|
Company |
1.3%
|
2,447,876
|
$218,277,000 | — | 31 Dec 2017 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.3%
|
2,422,414
|
$216,007,000 | — | 31 Dec 2017 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.2%
|
2,315,075
|
$206,435,000 | — | 31 Dec 2017 | |
| Manning & Napier Group, LLC |
13F
|
Company |
1%
|
1,980,877
|
$176,633,000 | — | 31 Dec 2017 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.91%
|
1,751,391
|
$156,172,000 | — | 31 Dec 2017 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.9%
|
1,736,686
|
$154,860,000 | — | 31 Dec 2017 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.89%
|
1,710,572
|
$152,550,000 | — | 31 Dec 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.88%
|
1,706,339
|
$152,154,000 | — | 31 Dec 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.82%
|
1,582,785
|
$141,138,000 | — | 31 Dec 2017 | |
| Capital World Investors |
13F
|
Company |
0.75%
|
1,454,610
|
$129,708,000 | — | 31 Dec 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.75%
|
1,452,491
|
$129,519,000 | — | 31 Dec 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.75%
|
1,446,179
|
$128,882,000 | — | 31 Dec 2017 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.7%
|
1,347,166
|
$120,127,000 | — | 31 Dec 2017 | |
| OppenheimerFunds, Inc. |
13F
|
Company |
0.68%
|
1,317,134
|
$117,449,000 | — | 31 Dec 2017 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.68%
|
1,305,418
|
$116,404,000 | — | 31 Dec 2017 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
0.62%
|
1,189,524
|
$106,070,000 | — | 31 Dec 2017 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.59%
|
1,138,342
|
$101,505,956 | — | 31 Dec 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.58%
|
1,110,032
|
$98,981,000 | — | 31 Dec 2017 | |
| USS Investment Management Ltd |
13F
|
Company |
0.56%
|
1,089,933
|
$97,184,000 | — | 31 Dec 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.55%
|
1,053,254
|
$93,920,000 | — | 31 Dec 2017 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.55%
|
1,052,144
|
$93,816,000 | — | 31 Dec 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.53%
|
1,030,302
|
$91,864,000 | — | 31 Dec 2017 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.53%
|
1,024,032
|
$91,313,000 | — | 31 Dec 2017 | |
| TCW GROUP INC |
13F
|
Company |
0.52%
|
1,001,764
|
$89,327,000 | — | 31 Dec 2017 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.49%
|
944,708
|
$84,239,000 | — | 31 Dec 2017 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.48%
|
920,762
|
$82,104,000 | — | 31 Dec 2017 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.47%
|
901,864
|
$80,419,000 | — | 31 Dec 2017 | |
| NORGES BANK |
13F
|
Company |
0.46%
|
878,056
|
$78,295,000 | — | 31 Dec 2017 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
0.43%
|
828,666
|
$73,892,000 | — | 31 Dec 2017 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.41%
|
787,455
|
$70,217,000 | — | 31 Dec 2017 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.4%
|
771,715
|
$68,814,000 | — | 31 Dec 2017 | |
| Legal & General Group Plc |
13F
|
Company |
0.39%
|
757,463
|
$67,543,000 | — | 31 Dec 2017 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.39%
|
755,511
|
$67,368,000 | — | 31 Dec 2017 | |
| Swiss National Bank |
13F
|
Company |
0.33%
|
646,100
|
$57,613,000 | — | 31 Dec 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.33%
|
634,864
|
$56,611,000 | — | 31 Dec 2017 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.3%
|
585,838
|
$52,239,000 | — | 31 Dec 2017 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.3%
|
577,676
|
$51,511,000 | — | 31 Dec 2017 |
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) as of Q1 2018
As of 31 Mar 2018,
BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) was held by
421 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
180,119,807 shares.
The largest 10 holders included
Capital Research Global Investors, VANGUARD GROUP INC, PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., JENNISON ASSOCIATES LLC, BAKER BROS. ADVISORS LP, SANDS CAPITAL MANAGEMENT, LLC, Invesco Ltd., FMR LLC, and STATE STREET CORP.
This page lists
421
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2018 vs Q4 2017 Across Filers
Q4 2017 holders
431
Q1 2018 holders
421
Holder diff
-10
| Investor | Q4 2017 Shares | Q1 2018 Shares | Share Diff | Share Chg % | Q4 2017 Value $ | Q1 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.